IMM 1.56% 32.5¢ immutep limited

Would this be released before the conference? Conference:...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 102 Posts.
    lightbulb Created with Sketch. 2
    Would this be released before the conference?

    Conference: Society for Immunotherapy of Cancer (SITC) Annual Meeting

    Dates: November 7-11, 2018

    Results from a Phase I dose escalation trial (TACTI-mel) with the soluble LAG-3 protein (IMP321, eftilagimod alpha) together with pembrolizumab in unresectable or metastatic melanoma
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
32.5¢
Change
0.005(1.56%)
Mkt cap ! $486.6M
Open High Low Value Volume
32.0¢ 32.5¢ 31.5¢ $465.8K 1.452M

Buyers (Bids)

No. Vol. Price($)
3 587491 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 18585 2
View Market Depth
Last trade - 16.10pm 29/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.